The trajectory of Viagra presents a intricate picture for shareholders. While the initial introduction generated significant gains, the lapse of its intellectual property protection opened the door to off-brand https://deborahjmpi340160.elbloglibre.com/42216030/the-copyright-and-the-pharmaceutical-industry-a-risky-bet